EUVIMEDEUVIMED entdecken
Crossref

Breast Cancer Tumor Staging via Serum ATR ‐ FTIR Spectroscopy: A Feasibility Study

Meagha K Vithanage iD, Sachini H Ekanayake, Hemendra Ghimire, Mathes K Dayananda, Gengsheng Qin iD, Emiel A M Janssen iD, A G Unil Perera iD, PBCB‐study group

Journal of Biophotonics · 2026-11 · 19 (11)

DOI: 10.1002/jbio.70377 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biophotonics, online erschienen am 15.11.2026. Verfasst von Meagha K Vithanage und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics and Astronomy, Georgia State University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Blood Chemical Analysis. Die Arbeit nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood serum analysis using attenuated total reflectance–Fourier transform infrared (ATR–FTIR) spectroscopy has emerged as a promising approach for breast cancer (BC) detection, yet its application in monitoring tumor progression remains limited. This study establish a proof of principle for ATR–FTIR spectroscopy as a minimally invasive, label‐free method to detect molecular alterations associated with BC progression. A total of 48 serum spectra ‐ were analyzed, including controls (CN, ) and BC patients stratified into T1, T2, and T3 groups ( each). An independent cohort (10 BC, 10 CN) validated performance. Curve fitting identified five Spectral Biomarkers (SBMs) with statistically significant differences (–) and stage‐dependent trends. Principal component analysis (PCA) demonstrated separation between CN and BC groups, while receiver operating characteristic (ROC) analysis yielded area under the curve (AUC) values of 0.85–1.0. This approach provides a foundation for future large‐scale studies towards potential clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBlood Chemical AnalysisHumansSpectroscopy, Fourier Transform InfraredFeasibility StudiesFemaleNeoplasm StagingPrincipal Component AnalysisBiomarkers, TumorMiddle Aged

Stichwörter der Autor:innen

ATR–FTIR spectroscopyT–stageblood serumbreast cancerspectral biomarkers

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Physics and Astronomy, Georgia State University, Atlanta, Georgia, USA.
  • Department of Physics, Georgia State University-Perimeter College, Atlanta, Georgia, USA.
  • Department of Mathematics and Statistics, Georgia State University, Atlanta, Georgia, USA.
  • Department of Pathology, Stavanger University Hospital, Stavanger, Norway.

ORCID-Profile: Meagha K Vithanage, Gengsheng Qin, Emiel A M Janssen, A G Unil Perera

Zitieren

APA

Vithanage, M. K., Ekanayake, S. H., Ghimire, H., Dayananda, M. K., Qin, G., Janssen, E. A. M., Perera, A. G. U., & PBCB‐study group (2026). Breast Cancer Tumor Staging via Serum ATR ‐ FTIR Spectroscopy: A Feasibility Study. Journal of Biophotonics, 19(11). https://doi.org/10.1002/jbio.70377

Vancouver

Vithanage MK, Ekanayake SH, Ghimire H, Dayananda MK, Qin G, Janssen EAM, et al. Breast Cancer Tumor Staging via Serum ATR ‐ FTIR Spectroscopy: A Feasibility Study. Journal of Biophotonics. 2026;19(11). doi:10.1002/jbio.70377

BibTeX
@article{Vithanage2026,
  author = {Vithanage, Meagha K and Ekanayake, Sachini H and Ghimire, Hemendra and Dayananda, Mathes K and Qin, Gengsheng and Janssen, Emiel A M and Perera, A G Unil and PBCB‐study group, PBCB‐study group},
  title = {Breast Cancer Tumor Staging via Serum ATR ‐ FTIR Spectroscopy: A Feasibility Study},
  journal = {Journal of Biophotonics},
  year = {2026},
  volume = {19},
  number = {11},
  doi = {10.1002/jbio.70377}
}
Kostenlos starten →